Market Price Fluctuation Risk for Investment Securities
First written in FY2017. 10 of 22 entries say "Mitigated", first in FY2021-Q1. Latest entry: 2026-08-07.
The whole theme swung hardest in 2019: 35 of 106 companies on the "Worse" side.
25 other companies' latest entry also says "Mitigated".
- 2026-08-07MitigatedResults
「The valuation difference on other securities increased by ¥104 million」
The valuation difference on other securities increased, improving the valuation differences on investment securities. - FY2026MitigatedAnnual report
「Valuation difference on available-for-sale securities 266,376 443,293」
The valuation difference on available-for-sale securities increased from ¥266 million at the end of the previous fiscal year to ¥443 million, indicating an improvement in valuation differences on investment securities. - FY2026-H1MitigatedAnnual report
「Valuation difference on available-for-sale securities 266,376 355,902」
The valuation difference on available-for-sale securities increased from ¥266.376 million at the end of the previous fiscal year to ¥355.902 million, indicating an improvement in valuation differences. - FY2025MitigatedAnnual report
「Valuation difference on available-for-sale securities 210,699 266,376」
The valuation difference on available-for-sale securities increased from ¥210.699 million at the end of the previous fiscal year to ¥266.376 million, indicating an improvement in valuation differences. The company also sold investment securities for ¥152.07 million. - FY2024-Q3Quarter-on-quarter decrease in valuation differencesAnnual report
「Valuation difference on available-for-sale securities 58,845 118,597」
The valuation difference on available-for-sale securities increased from ¥58.845 million at the end of the previous consolidated fiscal year to ¥118.597 million, but decreased from ¥143.777 million reported in the previous quarterly report. The improvement in valuation differences caused by market price fluctuations narrowed. - FY2024-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities 58,845 143,777」
The valuation difference on available-for-sale securities increased from ¥58.845 million at the end of the previous consolidated fiscal year to ¥143.777 million, indicating an improvement in valuation differences. - FY2024-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 58,845 83,984」
The valuation difference on available-for-sale securities increased from ¥58.845 million at the end of the previous consolidated fiscal year to ¥83.984 million, indicating an improvement in valuation differences on investment securities. - FY2023MitigatedAnnual report
「Valuation difference on available-for-sale securities 20,297 58,845」
The valuation difference on available-for-sale securities increased from ¥20.29 million at the end of the previous fiscal year to ¥58.84 million, indicating an improvement in valuation differences caused by market price fluctuations. - FY2023-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities 20,297 22,406」
The valuation difference on available-for-sale securities increased from ¥20.297 million at the end of the previous consolidated fiscal year to ¥22.406 million, indicating an improvement in valuation differences. - FY2023-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities 20,297 13,423」
The valuation difference on available-for-sale securities decreased from ¥20.297 million at the end of the previous consolidated fiscal year to ¥13.423 million, resulting in a deterioration in valuation differences associated with fluctuations in the market prices of investment securities. - FY2022Improvement in valuation differences alongside an increase in investment securitiesAnnual report
「Valuation difference on available-for-sale securities 15,279 20,297」
While the valuation difference on available-for-sale securities improved from ¥15 million at the end of the previous fiscal year to ¥20 million, investment securities increased from ¥689 million to ¥1.022 billion, and the company also incurred ¥364 million in acquisition spending during the period. - FY2022-Q2MaterialisedAnnual report
「Impairment loss on investment securities － 30,111」
During the six-month period ended in the second quarter, the company recognized an impairment loss on investment securities of ¥30.11 million as an extraordinary loss, resulting in a loss related to market price fluctuations and other factors. - FY2022-Q1MaterialisedAnnual report
「Extraordinary loss Impairment loss on investment securities － 31,682」
In the first quarter, the company recognized an impairment loss on investment securities of ¥31.682 million as an extraordinary loss, resulting in a loss related to fluctuations in the market prices of investment securities and other factors. The valuation difference on available-for-sale securities recovered from ¥15.279 million to ¥24.205 million. - FY2021Recovery in valuation differences alongside impairment of unlisted sharesAnnual report
「Valuation difference on available-for-sale securities △ 59,263 15,279」
While the valuation difference on available-for-sale securities recovered from negative ¥59 million at the end of the previous fiscal year to ¥15 million, the company recognized an impairment loss of ¥50 million on investment securities consisting of unlisted shares. - FY2021-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 59,263 △ 43,502」
The valuation difference on available-for-sale securities improved from negative ¥59 million at the end of the previous consolidated fiscal year to negative ¥43 million, with part of the deterioration caused by market price fluctuations narrowing. - FY2021-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 59,263 △ 35,592」
The valuation difference on available-for-sale securities improved from negative ¥59.263 million at the end of the previous consolidated fiscal year to negative ¥35.592 million, with part of the deterioration caused by market price fluctuations narrowing. - FY2020MaterialisedAnnual report
「Valuation difference on available-for-sale securities 31,291 △59,263」
The valuation difference on available-for-sale securities decreased from ¥31.291 million at the end of the previous fiscal year to negative ¥59.263 million, resulting in a deterioration in valuation differences caused by market price fluctuations for the year. - FY2020-Q3Recovery in valuation differencesAnnual report
「Valuation difference on available-for-sale securities 31,291 38,093」
The valuation difference on available-for-sale securities increased from ¥31.291 million at the end of the previous consolidated fiscal year to ¥38.093 million, recovering from the decrease through the second quarter. - FY2020-Q2MaterialisedAnnual report
「Valuation difference on available-for-sale securities 31,291 18,299」
The valuation difference on available-for-sale securities decreased from ¥31.291 million at the end of the previous consolidated fiscal year to ¥18.299 million, and the deterioration in valuation differences caused by market price fluctuations continued. - FY2020-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities 31,291 16,323」
The valuation difference on available-for-sale securities decreased from ¥31.291 million at the end of the previous consolidated fiscal year to ¥16.323 million, indicating a deterioration in valuation differences caused by fluctuations in the market prices of investment securities. - FY2019MaterialisedAnnual report
「Valuation difference on available-for-sale securities △98,587」
Amid disclosure of market price fluctuation risk, the valuation difference on available-for-sale securities changed from an increase of ¥34.72 million in the previous fiscal year to a decrease of ¥98.58 million. - FY2017First statedAnnual report
「Investment securities are shares of companies with which we have business relationships and are exposed to market price fluctuation risk.」
The company discloses its holdings of shares in companies with which it has business relationships, the risk of exposure to fluctuations in market prices, and its management of that risk through regular monitoring of fair values and issuers' financial condition.